Annual ROE
39.84%
+112.27%+155.00%
December 1, 2023
Summary
- As of February 8, 2025, CAMP annual return on equity is 39.84%, with the most recent change of +112.27% (+155.00%) on December 1, 2023.
- During the last 3 years, CAMP annual ROE has risen by +88.17% (+182.43%).
- CAMP annual ROE is now -36.38% below its all-time high of 62.62%, reached on February 28, 2013.
Performance
CAMP ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
21.01%
-13.57%-39.24%
September 1, 2024
Summary
- As of February 8, 2025, CAMP quarterly return on equity is 21.01%, with the most recent change of -13.57% (-39.24%) on September 1, 2024.
- Over the past year, CAMP quarterly ROE has increased by +156.44% (+115.51%).
- CAMP quarterly ROE is now -93.10% below its all-time high of 304.62%, reached on November 30, 2023.
Performance
CAMP Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
CAMP ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -30.1% | +115.5% |
| 3 y3 years | +182.4% | +130.9% |
| 5 y5 years | +337.8% | +143.0% |
CAMP ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -30.1% | +155.0% | -93.1% | +109.0% |
| 5 y | 5-year | -30.1% | +155.0% | -93.1% | +109.0% |
| alltime | all time | -36.4% | +129.0% | -93.1% | +104.9% |
CAMP4 Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | 21.01%(-39.2%) |
| Jun 2024 | - | 34.58%(-72.9%) |
| Dec 2023 | 39.84%(-155.0%) | 127.79%(-58.0%) |
| Nov 2023 | - | 304.62%(-230.1%) |
| Sep 2023 | - | -234.08%(+72.8%) |
| Aug 2023 | - | -135.43%(+6.6%) |
| May 2023 | - | -127.01%(+24.2%) |
| Feb 2023 | - | -102.29%(+36.9%) |
| Feb 2023 | -72.43%(-227.1%) | - |
| Dec 2022 | 57.00%(-273.6%) | - |
| Nov 2022 | - | -74.73%(+9.9%) |
| Aug 2022 | - | -67.98%(+31.7%) |
| May 2022 | - | -51.61%(+61.0%) |
| Feb 2022 | -32.84%(-32.1%) | -32.05%(+7.2%) |
| Nov 2021 | - | -29.89%(-25.0%) |
| Aug 2021 | - | -39.83%(-2.9%) |
| May 2021 | - | -41.02%(-16.0%) |
| Feb 2021 | -48.33%(+4.7%) | -48.84%(-36.5%) |
| Nov 2020 | - | -76.93%(+35.2%) |
| Aug 2020 | - | -56.88%(+13.2%) |
| May 2020 | - | -50.25%(+17.4%) |
| Feb 2020 | -46.16%(-607.3%) | -42.79%(+593.5%) |
| Nov 2019 | - | -6.17%(+133.7%) |
| Aug 2019 | - | -2.64%(-547.5%) |
| May 2019 | - | 0.59%(-93.5%) |
| Feb 2019 | 9.10%(-0.9%) | 9.03%(+671.8%) |
| Nov 2018 | - | 1.17%(-84.1%) |
| Aug 2018 | - | 7.36%(-49.0%) |
| May 2018 | - | 14.43%(+60.3%) |
| Feb 2018 | 9.18%(-304.9%) | 9.00%(-6.3%) |
| Nov 2017 | - | 9.60%(+340.4%) |
| Aug 2017 | - | 2.18%(-148.3%) |
| May 2017 | - | -4.51%(+1.8%) |
| Feb 2017 | -4.48%(-145.1%) | -4.43%(-538.6%) |
| Nov 2016 | - | 1.01%(-74.4%) |
| Aug 2016 | - | 3.95%(-29.7%) |
| May 2016 | - | 5.62%(-42.1%) |
| Feb 2016 | 9.94%(-14.3%) | 9.71%(-10.6%) |
| Nov 2015 | - | 10.86%(-6.0%) |
| Aug 2015 | - | 11.55%(-3.8%) |
| May 2015 | - | 12.01%(+2.4%) |
| Feb 2015 | 11.60%(+23.1%) | 11.73%(+22.2%) |
| Nov 2014 | - | 9.60%(-4.7%) |
| Aug 2014 | - | 10.07%(+0.5%) |
| May 2014 | - | 10.02%(+5.3%) |
| Feb 2014 | 9.42%(-85.0%) | 9.52%(-75.8%) |
| Nov 2013 | - | 39.31%(-17.7%) |
| Aug 2013 | - | 47.77%(-22.7%) |
| May 2013 | - | 61.79%(-31.9%) |
| Feb 2013 | 62.62%(+155.5%) | 90.72%(+101.0%) |
| Nov 2012 | - | 45.14%(+6.6%) |
| Aug 2012 | - | 42.33%(+11.2%) |
| May 2012 | - | 38.07%(+52.0%) |
| Feb 2012 | 24.51%(-237.4%) | 25.04%(+23.5%) |
| Nov 2011 | - | 20.28%(+82.7%) |
| Aug 2011 | - | 11.10%(-789.4%) |
| May 2011 | - | -1.61%(-91.6%) |
| Feb 2011 | -17.84%(-65.1%) | -19.19%(-31.4%) |
| Nov 2010 | - | -27.96%(-22.6%) |
| Aug 2010 | - | -36.12%(-32.6%) |
| May 2010 | - | -53.63%(-7.7%) |
| Feb 2010 | -51.19%(-50.2%) | -58.10%(-70.0%) |
| Nov 2009 | - | -193.64%(+37.7%) |
| Aug 2009 | - | -140.59%(+35.3%) |
| May 2009 | - | -103.94%(+29.4%) |
| Feb 2009 | -102.81%(+37.2%) | -80.34%(+340.9%) |
| Nov 2008 | - | -18.22%(-77.5%) |
| Aug 2008 | - | -81.10%(+11.6%) |
| May 2008 | - | -72.65%(+0.6%) |
| Feb 2008 | -74.91%(+293.2%) | -72.19%(+28.7%) |
| Nov 2007 | - | -56.08%(+478.1%) |
| Aug 2007 | - | -9.70%(+67.8%) |
| May 2007 | - | -5.78%(-71.4%) |
| Feb 2007 | -19.05%(-318.7%) | -20.24%(+12.4%) |
| Nov 2006 | - | -18.00%(+21.1%) |
| Aug 2006 | - | -14.86%(+13.2%) |
| May 2006 | - | -13.13%(-249.7%) |
| Feb 2006 | 8.71%(+20.6%) | 8.77%(-1.0%) |
| Nov 2005 | - | 8.86%(+31.1%) |
| Aug 2005 | - | 6.76%(+20.1%) |
| May 2005 | - | 5.63%(-5.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Feb 2005 | 7.22%(-21.7%) | 5.93%(-11.2%) |
| Nov 2004 | - | 6.68%(-31.2%) |
| Aug 2004 | - | 9.71%(-6.1%) |
| May 2004 | - | 10.34%(+9.1%) |
| Feb 2004 | 9.22%(-14.1%) | 9.48%(+49.8%) |
| Nov 2003 | - | 6.33%(+210.3%) |
| Aug 2003 | - | 2.04%(-57.0%) |
| May 2003 | - | 4.74%(-53.4%) |
| Feb 2003 | 10.73%(-19.2%) | 10.17%(-9.3%) |
| Nov 2002 | - | 11.21%(-17.7%) |
| Aug 2002 | - | 13.62%(-15.4%) |
| May 2002 | - | 16.09%(+19.0%) |
| Feb 2002 | 13.28%(-38.5%) | 13.52%(+19.6%) |
| Nov 2001 | - | 11.30%(-8.4%) |
| Aug 2001 | - | 12.34%(+18.0%) |
| May 2001 | - | 10.46%(-32.8%) |
| Feb 2001 | 21.59%(-182.8%) | 15.57%(-265.8%) |
| Nov 2000 | - | -9.39%(-20.8%) |
| Aug 2000 | - | -11.86%(-26.0%) |
| May 2000 | - | -16.02%(-31.6%) |
| Feb 2000 | -26.09%(+280.9%) | -23.41%(-269.6%) |
| Nov 1999 | - | 13.80%(+143.4%) |
| Aug 1999 | - | 5.67%(-282.3%) |
| May 1999 | - | -3.11%(-58.1%) |
| Feb 1999 | -6.85%(-41.9%) | -7.43%(-57.0%) |
| Nov 1998 | - | -17.27%(-12.3%) |
| Aug 1998 | - | -19.70%(+38.3%) |
| May 1998 | - | -14.24%(+25.4%) |
| Feb 1998 | -11.79%(-562.4%) | -11.36%(+84.7%) |
| Nov 1997 | - | -6.15%(+201.5%) |
| Aug 1997 | - | -2.04%(-44.4%) |
| May 1997 | - | -3.67%(-248.0%) |
| Feb 1997 | 2.55%(-90.4%) | 2.48%(-81.9%) |
| Nov 1996 | - | 13.69%(-33.3%) |
| Aug 1996 | - | 20.51%(-28.2%) |
| May 1996 | - | 28.57%(+2.7%) |
| Feb 1996 | 26.46%(+43.4%) | 27.81%(+9.8%) |
| Nov 1995 | - | 25.33%(+10.3%) |
| Aug 1995 | - | 22.97%(+9.0%) |
| May 1995 | - | 21.07%(+13.1%) |
| Feb 1995 | 18.45%(+12.4%) | 18.63%(+40.9%) |
| Nov 1994 | - | 13.22%(+1.8%) |
| Aug 1994 | - | 12.99%(-3.7%) |
| May 1994 | - | 13.49%(-17.2%) |
| Feb 1994 | 16.41%(-70.9%) | 16.29%(-44.9%) |
| Nov 1993 | - | 29.55%(-18.0%) |
| Aug 1993 | - | 36.02%(-19.4%) |
| May 1993 | - | 44.68%(-22.2%) |
| Feb 1993 | 56.36%(+0.4%) | 57.41%(-9.0%) |
| Nov 1992 | - | 63.06%(-15.0%) |
| Aug 1992 | - | 74.18%(-4.5%) |
| May 1992 | - | 77.70%(+20.4%) |
| Feb 1992 | 56.14%(-324.6%) | 64.52%(+57.7%) |
| Nov 1991 | - | 40.91%(-1031.9%) |
| Aug 1991 | - | -4.39%(-75.9%) |
| May 1991 | - | -18.18%(-0.9%) |
| Feb 1991 | -25.00%(-337.4%) | -18.35%(+30.9%) |
| Nov 1990 | - | -14.02%(-175.7%) |
| Aug 1990 | - | 18.52%(-9.3%) |
| May 1990 | - | 20.41%(+83.7%) |
| Feb 1990 | 10.53%(-123.4%) | 11.11%(-200.0%) |
| Nov 1989 | - | -11.11%(-71.4%) |
| Aug 1989 | - | -38.89%(-30.0%) |
| May 1989 | - | -55.56%(+94.5%) |
| Feb 1989 | -45.00%(-977.2%) | -28.57%(-10.2%) |
| Nov 1988 | - | -31.82%(+250.1%) |
| Aug 1988 | - | -9.09%(-299.8%) |
| May 1988 | - | 4.55%(+38.7%) |
| Feb 1988 | 5.13%(-61.5%) | 3.28%(-86.1%) |
| Nov 1987 | - | 23.53%(+33.3%) |
| Aug 1987 | - | 17.65%(0.0%) |
| May 1987 | - | 17.65%(+50.1%) |
| Feb 1987 | 13.33%(-109.7%) | 11.76%(-103.5%) |
| Nov 1986 | - | -338.46%(-13.7%) |
| Aug 1986 | - | -392.31%(-5.6%) |
| May 1986 | - | -415.38%(-3.6%) |
| Feb 1986 | -137.35%(+1570.9%) | -430.77%(+1156.3%) |
| Nov 1985 | - | -34.29%(+41.2%) |
| Aug 1985 | - | -24.29%(-5.5%) |
| May 1985 | - | -25.71%(+260.1%) |
| Feb 1985 | -8.22%(-126.0%) | -7.14% |
| Feb 1984 | 31.58% | - |
FAQ
- What is CAMP4 Therapeutics annual return on equity?
- What is the all time high annual ROE for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics annual ROE year-on-year change?
- What is CAMP4 Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for CAMP4 Therapeutics?
- What is CAMP4 Therapeutics quarterly ROE year-on-year change?
What is CAMP4 Therapeutics annual return on equity?
The current annual ROE of CAMP is 39.84%
What is the all time high annual ROE for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high annual return on equity is 62.62%
What is CAMP4 Therapeutics annual ROE year-on-year change?
Over the past year, CAMP annual return on equity has changed by -17.16% (-30.11%)
What is CAMP4 Therapeutics quarterly return on equity?
The current quarterly ROE of CAMP is 21.01%
What is the all time high quarterly ROE for CAMP4 Therapeutics?
CAMP4 Therapeutics all-time high quarterly return on equity is 304.62%
What is CAMP4 Therapeutics quarterly ROE year-on-year change?
Over the past year, CAMP quarterly return on equity has changed by +156.44% (+115.51%)